Revance Therapeutics, Inc.( NASDAQ:RVNC ) Sector: Health Technology (Pharmaceuticals: Major) Market Capitalization: $2.124B Current Price: $29.17 Breakout price: $30.00 Buy Zone (Top/Bottom Range): $27.45-$24.15 Price Target: $41.10-$42.00 Estimated Duration to Target: 132-142d Contract of Interest: $RVNC 1/20/23 30c Trade price as of publish date: $3.70/contract
Here we have a clear gap to fill with momentum having shifted to the upside and of course insider buying as titled. Watch for continuation and set a short stop. NFA, DYOR
Ravencoin is a free and open source project & fairly mined (POW) blockchain. Users can issue and control utility, game & securities digital assets/ tokens. Ravencoin is a peer-to-peer blockchain, handling the efficient creation and transfer of assets from one party to another. Ravencoin is a protocol based on a fork of the Bitcoin code which adds features...
RVNC jumped on a successful phase 3 clinical trials. It held its ground however there was a blow of top and retracement. (for education purposes)